Oral Tirzepatide Ads Could Conflict with Meta’s Ad Policy, Raise Other Legal Questions

Published on Jan 20, 2026

In December, the attorneys general of 35 U.S. states and territories wrote a letter calling on Meta to address “the surge of misleading marketing for weight loss products on Meta’s platforms,” particularly for compounded GLP-1 products, which do not have Food and Drug Administration (FDA) approval. The attorneys general said ads that include inaccurate claims…

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.